This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Arestat™ is based on a number of fundamentally novel insights into interactions between formulation excipients and proteins, allowing control of protein behaviour under various stress conditions.
The application of this technology can deliver differentiation in the form of products with superior kinetics, stable ready-to-administer products for IV delivery, concentrated liquid doses for self-administration, and desirable pharmacokinetic and pharmacodynamic profiles.
The various aspects of our Arestat™ technology platform are protected by over 50 granted patents, and 20 pending patent applications.